Upcoming catalysts and material SEC filings for Cartesian Therapeutics, Inc. (RNAC). 1 upcoming catalyst.
Trial readout (estimated)
Q1 2027 · Estimated — subject to change
Extracted from the company's SEC 8-K filings (EDGAR). Estimated dates can change.
SEC EDGAR · 5d ago